Eric Cantor named new president of pharma trade group

Eric Cantor, who previously served as the Republican House Majority Leader, has been named the new president of PhRMA, the top lobbying and trade organization for the U.S. pharmaceutical industry. This move is significant as PhRMA wields considerable influence over healthcare policy and drug regulation in the U.S. Cantor's leadership could shape the industry's future direction, particularly in areas like drug pricing and healthcare reform, making this transition noteworthy for policymakers and industry stakeholders alike.